tiprankstipranks
Filament Health Advances Coca Leaf Import for Drug Development
Company Announcements

Filament Health Advances Coca Leaf Import for Drug Development

Story Highlights

Filament Health Corp. (TSE:FH) has released an update.

Pick the best stocks and maximize your portfolio:

Filament Health Corp. and its joint venture, Magdalena Biosciences, have successfully imported six kilograms of coca leaf from Peru to Canada for developing natural prescription medicines targeting mental health conditions, such as ADHD. This marks their second authorized import, highlighting their commitment to exploring the therapeutic potential of coca leaf. The collaboration with the Peruvian government underscores the significant regulatory achievement for Filament Health in the psychedelic drug development space.

For further insights into TSE:FH stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskFilament Health Expands IP Portfolio Amid Q3 Growth
TipRanks Canadian Auto-Generated NewsdeskFilament Health Issues Shares to Strategic Advisor
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App